Posted On: 11/28/2014 7:16:35 PM
Post# of 297
UC San Francisco and OncoSec Medical Collaborate to Evaluate Investigational Combination of ImmunoPulse and Anti-PD-1 Treatment
| Tuesday, November 25, 2014 2:16 AM |
[at noodls] - Investigator Sponsored Trial Led by Dr. Alain Algazi and Supported by OncoSec and Merck Will Evaluate Combination of KEYTRUDA® and ImmunoPulse in Metastatic Melanoma SAN DIEGO-- OncoSec Medical Inc. (OTCQB: ...
http://us.rd.yahoo.com/finance/external/noodl...27D3F6D05E
~ This Week's OTC News In Review! ~
Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html
~ http://www.fallenheroesfund.org/ ~
St. Jude 2014 Drive has started >> http://tinyurl.com/St-Jude-2014
| Tuesday, November 25, 2014 2:16 AM |
[at noodls] - Investigator Sponsored Trial Led by Dr. Alain Algazi and Supported by OncoSec and Merck Will Evaluate Combination of KEYTRUDA® and ImmunoPulse in Metastatic Melanoma SAN DIEGO-- OncoSec Medical Inc. (OTCQB: ...
http://us.rd.yahoo.com/finance/external/noodl...27D3F6D05E
~ This Week's OTC News In Review! ~
Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html
~ http://www.fallenheroesfund.org/ ~
St. Jude 2014 Drive has started >> http://tinyurl.com/St-Jude-2014
(0)
(0)Scroll down for more posts ▼
